JP2023522065A5 - - Google Patents

Info

Publication number
JP2023522065A5
JP2023522065A5 JP2022563012A JP2022563012A JP2023522065A5 JP 2023522065 A5 JP2023522065 A5 JP 2023522065A5 JP 2022563012 A JP2022563012 A JP 2022563012A JP 2022563012 A JP2022563012 A JP 2022563012A JP 2023522065 A5 JP2023522065 A5 JP 2023522065A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
acid
composition according
item
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522065A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/087690 external-priority patent/WO2021209025A1/en
Publication of JP2023522065A publication Critical patent/JP2023522065A/ja
Publication of JP2023522065A5 publication Critical patent/JP2023522065A5/ja
Pending legal-status Critical Current

Links

JP2022563012A 2020-04-17 2021-04-16 医薬組成物 Pending JP2023522065A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020085241 2020-04-17
CNPCT/CN2020/085241 2020-04-17
PCT/CN2021/087690 WO2021209025A1 (en) 2020-04-17 2021-04-16 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2023522065A JP2023522065A (ja) 2023-05-26
JP2023522065A5 true JP2023522065A5 (enExample) 2024-04-26

Family

ID=78084668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563012A Pending JP2023522065A (ja) 2020-04-17 2021-04-16 医薬組成物

Country Status (8)

Country Link
US (1) US20230128252A1 (enExample)
EP (1) EP4135699A4 (enExample)
JP (1) JP2023522065A (enExample)
KR (1) KR20230004644A (enExample)
CN (1) CN115135323A (enExample)
AU (1) AU2021255559A1 (enExample)
CA (1) CA3180160A1 (enExample)
WO (1) WO2021209025A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024544075A (ja) * 2021-11-30 2024-11-27 マンカインド コーポレイション ブルーリ潰瘍におけるマイコバクテリウム・ウルセランスの局所治療のための製剤及び方法
CN116115563B (zh) * 2023-03-30 2023-08-29 石家庄四药有限公司 一种氟比洛芬混悬注射液及其制备方法
WO2025026423A1 (en) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, their use and manufacture for treatment of gastrointestinal conditions
CN117731649B (zh) * 2023-12-21 2025-01-28 博济医药科技股份有限公司 一种氨甲环酸药物组合物及其制备工艺
CN119837856A (zh) * 2024-12-11 2025-04-18 江南大学 一种具有预防和改善特应性皮炎的黄酮组合物及其应用
CN120865107B (zh) * 2025-09-22 2026-01-23 中国医学科学院医药生物技术研究所 一种苯吩嗪衍生物、其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814814C2 (de) * 1998-04-02 2002-01-31 Gerhard Steffan Wasserlösliche, Iminophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US10179159B2 (en) * 1999-10-22 2019-01-15 Scott Wepfer Topical anesthetic formulation
CA2617934A1 (en) * 2005-08-05 2007-02-15 Nuvo Research Inc. Transdermal drug delivery formulation
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
NZ707855A (en) * 2012-11-06 2018-11-30 Rochal Ind Llc Delivery of biologically-active agents using volatile, hydrophobic solvents
AU2014214547B2 (en) * 2013-02-08 2018-08-30 Luoda Pharma Limited Methods of treating topical microbial infections
US20160220710A1 (en) * 2015-01-30 2016-08-04 The Regents Of The University Of Michigan Compositions and methods for delivering pharmaceutical agents
CN105693668A (zh) * 2016-04-23 2016-06-22 贺玉皓 一种氯法齐明的药物组合物及其医药用途

Similar Documents

Publication Publication Date Title
TWI316857B (en) Topical composition
JP2020090499A (ja) 胃腸管に沿った医薬の標的化放出のためのｐＨ依存性担体、それによる組成物、ならびにこれらの製造および使用
NL8303412A (nl) Nieuwe topicaal toepasbare farmaceutische samenstellingen.
RU2011141102A (ru) Обогащенные омега-3 рыбные парентеральные питательные эмульсии типа масло в воде
JP5864735B2 (ja) 非経口オキアミ油の治療用途
MX2007001558A (es) Formulaciones novedosas de fenofibrato y metodos de tratamiento relacionados.
WO2000049992A2 (en) USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS
JP2010509204A5 (enExample)
JP2020105183A (ja) 低水溶性薬剤の低融解イオン性塩の組成物および調製方法
US20230398132A1 (en) PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
JP2018515463A5 (enExample)
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
JP6050440B2 (ja) Ｄｈａエステルを含む非経口投与のための医薬組成物
JP2022538505A5 (enExample)
US12558359B2 (en) Composition having improved voluntary acceptance
RU2017137960A (ru) Применение тиаоксосоединений для уменьшения содержания аро сз
JP2018510206A5 (enExample)
US20170182074A1 (en) Liquid phospholipid-containing compositions for the preparation of pharmaceuticals
RU2323713C2 (ru) Косметическая и/или дерматологическая композиция
US20140017301A1 (en) Drug-free compositions and methods for diminishing peripheral inflammation and pain
CN104619311A (zh) 囊泡制剂、试剂盒和用途
JP2024525239A5 (enExample)
WO2011145660A1 (ja) プロポフォール含有水中油型エマルション組成物
CA3168635A1 (en) Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
JPH04244023A (ja) ω６系不飽和脂肪酸含有薬剤